se Of Oral Montelukast As Adjuvant Therapy In The Treatment Of Acute Asthma - Montelukast in Acute Asthma
- Conditions
- AsthmaMedDRA version: 9.1Level: LLTClassification code 10003553Term: Asthma
- Registration Number
- EUCTR2005-003074-20-GB
- Lead Sponsor
- niversity of Dundee
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 130
Inclusion Criteria
Acute asthma with peak flow of less than 75% predicted
Age 18 tom 65
Willingness to use effective contraception
Written informed consent
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Known or suspected hypersensitivity to Montelukast
Known or suspected pregnancy
Lactation
Use of a LRA within the 2 weeks prior to presentation
Any other significant concomitant respiratory disease
Any clinically significant disease that may, in the opinion of the investigators, affect evaluation of the study
Fever greater than 38C
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method